The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Search for Related Content
Related Collections
*Related Articles
Am J Psychiatry 161:A80, April 2004
© 2004 American Psychiatric Association

In This Issue

Legacy Depression Treatment?

Guidelines recommend antidepressants for drug treatment of depression. Nevertheless, use of benzodiazepines, a class of minor tranquilizers, is still widespread. Valenstein et al. (p. 654) report on 128,029 depressed veterans treated in mental health settings over 1 year. Nearly all received antidepressants, but 36% also received benzodiazepines. The doses were generally moderate, and records indicated that the patients actually took less than the prescribed amount. Several patient characteristics were associated with benzodiazepine use: white or Hispanic ethnicity, coexisting posttraumatic stress disorder or other anxiety disorder, and older age. Although older patients took lower doses, the risks of benzodiazepine use increase with age. Past use of benzodiazepines may prompt elderly patients to request them, and benzodiazepines do provide faster relief of sleeplessness, restlessness, and anxiety symptoms. It is not clear though whether the benefits outweigh the risks.

A Genetic Culprit in Autism

Autism apparently stems from the interaction of several genes. Research points to one such gene on chromosome 2. Ramoz et al. (p. 662) screened DNA from patients with autism for variants in nine candidate genes in the 2q31 region. Two single-nucleotide polymorphisms within the SLC25A12 gene showed significant association with autism, according to family-based tests of 2,000 people in 411 affected families. An allele of each genetic variant was preferentially transmitted from parent to affected child. The SLC25A12 gene encodes a mitochondrial aspartate/glutamate carrier. Since mitochondria provide cellular energy and neurons are major energy users, abnormalities in mitochondrial function could lead to changes in neuronal function. For both identified polymorphisms, the allele associated with autism is common, and so, while these variants significantly increase risk for autism, they cannot be considered sufficient for autism or appropriate for genetic counseling, without information about additional susceptibility genes.

Teens’ Personalities Reflect Parents’ Alcohol or Drug Abuse

The familial transmission of alcohol and drug disorders is partially genetic, but it could occur through intermediate factors that are also influenced by genes, such as personality traits. The time to assess personality in the offspring of parents with substance disorders is early, before the onset of similar disorders in the offspring obscures the contribution of personality as a risk factor. In a large sample of 17-year-olds, Elkins et al. (p. 670) related personality characteristics to the parents’ history of substance use disorders. The adolescents’ traits were significantly influenced by parental substance abuse but varied by the type of disorder. Parental alcoholism was associated with offspring traits reflecting negative emotionality and with lower well-being. The children of parents who abused drugs showed less constraint and greater feelings of social potency than offspring of parents with no drug history. These associations remained after exclusion of adolescents who already had alcohol or drug problems and thus have additional risk factors.

Schizophrenia Patients Who Take Too Little, or Too Much, of Their Drugs

Antipsychotic medications improve the symptoms and functioning of patients with schizophrenia, but many patients do not take their medications as prescribed. Identifying these patients could lead to interventions aimed at improving adherence and outcomes. Gilmer et al. (p. 692) examined risk factors among Medicaid beneficiaries with schizophrenia in San Diego County. Characteristics associated with nonadherence were lower age, substance abuse, Latino or African American ethnicity, and homelessness. Adherence was greater for patients taking clozapine (60%) than for patients taking other "atypical" antipsychotics (41%) or conventional antipsychotics (37%). Adherence paid off in terms of less hospitalization, although these savings did not totally offset the higher pharmacy costs. The highest total cost was for the 19% of patients who obtained more pills than were prescribed. Targeting this excess prescription filling could save over $1,000 a year per person in medication costs alone.

Individual Views of Brain Activation in Schizophrenia

The anterior cingulate cortex processes emotions and provides an interface for motor control, drive, and cognition. It attracts great interest for studies of schizophrenia, but because its anatomy varies considerably between individuals and the subregions have distinct functions, the differences between overall groups may not be reliable. In their comparison of healthy subjects and patients with schizophrenia, Heckers et al. (p. 707) employed a task that evokes robust, repeatable activation of the dorsal anterior cingulate cortex. Between-group differences in performance and brain activation were not significant, but the locations of activation were also examined individually. Maximum excitation of the medial wall occurred in the dorsal anterior cingulate cortex for 67% of the healthy subjects but only 16% of schizophrenia patients. The individual data revealed three distinct activation patterns, and some patients had no activation of the anterior cingulate cortex at all. These individual differences clarify and confirm the abnormality of the anterior cingulate cortex in schizophrenia.



View larger version (35K):
[in this window]
[in a new window]
 

FIGURE 1.



Images in Psychiatry

Cesare Lombroso, M.D., 1835-1909 (p. 624)



View larger version (140K):
[in this window]
[in a new window]
 

FIGURE 2.




Related Articles:

Cesare Lombroso, M.D., 1835–1909
Giuseppe Carrà and Francesco Barale
Am J Psychiatry 2004 161: 624. [Full Text] [PDF]

Benzodiazepine Use Among Depressed Patients Treated in Mental Health Settings
Marcia Valenstein, Kiran Khanujua Taylor, Karen Austin, Helen C. Kales, John F. McCarthy, and Frederic C. Blow
Am J Psychiatry 2004 161: 654-661. [Abstract] [Full Text] [PDF]

Linkage and Association of the Mitochondrial Aspartate/Glutamate Carrier SLC25A12 Gene With Autism
Nicolas Ramoz, Jennifer G. Reichert, Christopher J. Smith, Jeremy M. Silverman, Irina N. Bespalova, Kenneth L. Davis, and Joseph D. Buxbaum
Am J Psychiatry 2004 161: 662-669. [Abstract] [Full Text] [PDF]

The Effect of Parental Alcohol and Drug Disorders on Adolescent Personality
Irene J. Elkins, Matt McGue, Steve Malone, and William G. Iacono
Am J Psychiatry 2004 161: 670-676. [Abstract] [Full Text] [PDF]

Adherence to Treatment With Antipsychotic Medication and Health Care Costs Among Medicaid Beneficiaries With Schizophrenia
Todd P. Gilmer, Christian R. Dolder, Jonathan P. Lacro, David P. Folsom, Laurie Lindamer, Piedad Garcia, and Dilip V. Jeste
Am J Psychiatry 2004 161: 692-699. [Abstract] [Full Text] [PDF]

Anterior Cingulate Cortex Activation During Cognitive Interference in Schizophrenia
Stephan Heckers, Anthony P. Weiss, Thilo Deckersbach, Donald C. Goff, Robert J. Morecraft, and George Bush
Am J Psychiatry 2004 161: 707-715. [Abstract] [Full Text] [PDF]




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Search for Related Content
Related Collections
*Related Articles


Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org